Veterinary Medicine Information website

Drontal Cat Tablets

Authorised
  • Praziquantel
  • Pyrantel embonate
Download as PDF

Product identification

Medicine name:
Drontal Cat Tablets
Active substance:
  • Praziquantel
  • Pyrantel embonate
Target species:
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Praziquantel
    20.00
    milligram(s)
    /
    1.00
    Tablet
  • Pyrantel embonate
    230.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AA51
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Available in:
  • Ireland
Package description:
  • Container material: Polyethylene-coated aluminium blister Closure: Heat sealContainer colour: Silver or white colouredContainer sizes: Cartons containing 96 tablets
  • Container material: Polyethylene-coated aluminium blisterClosure: Heat sealContainer colour: Silver or white colouredContainer sizes: Cartons containing 24 tablets
  • Container material: Polyethylene-coated aluminium blisterClosure: Heat sealContainer colour: Silver or white colouredContainer sizes: Cartons containing 2 tablets
  • HISTORICAL PACK Container material: Aluminium foil blisterClosure: Heat sealContainer colour: Silver or white colouredContainer sizes: Cartons containing 2 tablets
  • HISTORICAL PACK Container material: Aluminium foil blisterClosure: Heat sealContainer colour: Silver or white colouredContainer sizes: Cartons containing 24 tablets
  • HISTORICAL PACK Container material: Aluminium foil blisterClosure: Heat sealContainer colour: Silver or white colouredContainer sizes: Cartons containing 96 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone) - Council Directive 81/851/EEC
Marketing authorisation holder:
  • Vetoquinol S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • KVP Pharma+Veterinaer Produkte GmbH
  • Vetoquinol S.A.
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10521/007/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 1/12/2024
Download